SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-08-009594
Filing Date
2008-11-26
Accepted
2008-11-26 16:30:40
Documents
2
Period of Report
2008-11-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. 8-K a5840410.htm 8-K 15308
2 EXHIBIT 99.1 a5840410-ex991.htm EX-99.1 5523
  Complete submission text file 0001157523-08-009594.txt   22415
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 081218411
SIC: 2836 Biological Products, (No Diagnostic Substances)